To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Of those patients who participated in PEGASUS-D FAS clinical trial, patient must sign the
informed consent form in order to participate in this extension study.
The medical records of the patients will be reviewed throughout the study.